Web NewDrugInformation.com

Olux Drug - Olux The trade name of the product as shown on the labeling. Dosage - AEROSOL, FOAM; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Clobetasol Propionate Multiple ingredients are in alphabetical order. Strength - 0.05% The potency of the active ingredient(s), Clobetasol Propionate. May repeat for multiple part products. Applicant - CONNETICS The firm name holding legal responsibility for Olux. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 021142 The FDA assigned number to Olux. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Olux. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - May 26, 2000 The date Olux was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Olux. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Olux is in. Format is RX, OTC, DISCN. Applicant Full Name - Connetics Corp The full name of the firm holding legal responsibility for the new application of Olux. Olux Clindamycin Phosphate Eq 1% Base Solution; Topical Clindamycin Phosphate Eq 1% Base Solution; Topical Clindamycin Phosphate Eq 1% Base Solution; Topical Clindamycin Phosphate Eq 1% Base Solution; Topical Cleocin 100mg Suppository; Vaginal Cleocin Eq 1% Base Swab; Topical Clindamycin Phosphate Eq 1% Base Swab; Topical Clindets Eq 1% Base Swab; Topical Nystaform 10mg/gm;100,000 Units/gm Ointment; Topical Olux 0.05% Aerosol, Foam; Topical NewDrugInformation